ArticleScientific reports2026

Association of RAS mutational status with clinical outcomes in metastatic colorectal cancer treated with trifluridine/tipiracil or regorafenib.

Meng-Che Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.